GHK-CU 100 mg — Third-Party Test Results
Manufacturer: LeoLab™ RX
Sample: GHK-CU 100 mg
Date: 07 OCT 2025
On September 30, 2025, LeoLab RX submitted a 100 mg sample of GHK-Cu (Batch CU870002) for independent third-party analysis by Janosik Analytical, a trusted laboratory specializing in pharmaceutical testing. The sample was received on October 3, 2025, and testing was registered under Task Number #81937. The analysis evaluated the batch for purity, identity, and mass content.
🔬Test Summary
-
Peptide Tested: GHK-Cu
-
Batch Number: CU870002
-
Nominal Quantity: 100 mg
-
Measured Mass: 103.09 mg
-
Purity: 99.855 %
✅ Review and Analysis
The third-party test conducted by Janosik Analytical confirmed a high level of purity for this batch, reaching 99.855 %, which exceeds typical industry standards. This result demonstrates a highly refined peptide with minimal impurities, suitable for precise and reproducible research applications that require stringent quality control.
The measured mass of 103.09 mg further verifies the product’s labeling accuracy and consistency, ensuring researchers receive the intended dosage. The identity of the compound was confirmed to match the expected molecular structure of GHK-Cu.
Purity 99.855%
Mass 103.09 mg
